In 2020,Emmanuel Charpentier and Jennifer A. Doudna won the Nobel prize in chemistry for their pioneering work on genome editing using Crispr technology.
In 2011,after meeting at a scientific conference, Charpentier and Doudna began collaborating on Crispr/Cas9 research related to bacterial immunity.
The first significant discovery they made was that bacteria uses a system to destroy the DNA of viruses that invade their cells.
Additionally guide RNA can be designed so that they are specific to only one sequence. It will increase the chance of DNA being cut there and nowhere else in the genome. Upon further testing, it was found that the system works quite well in human cells too.